UnitedHealth Beats Q3 Estimates and Raises Outlook
UnitedHealth reported third-quarter adjusted of $4.69 per share, beating the Zacks Consensus Estimate of $4.12 and rising 60.6% from a year earlier. Revenues reached $112.7 billion, slipping from $113.2 billion in the prior-year period as the company deliberately shed unprofitable members and markets. Operating earnings climbed to $6.6 billion from $4.3 billion, and net improved to 3.6% from 2.1%. The medical care ratio fell to 88.4% from 89.9% a year ago, aided by lower claims pressure, tighter pricing, and $610 million of favorable medical reserve development. Management raised its full-year adjusted earnings forecast to at least $20.50 per share from its previous $19.50 to $20 range. Total enrollment dropped as UnitedHealthcare served 48.3 million people, down from 50.1 million a year ago, with Advantage membership falling by 935,000 since the end of 2025. Despite the smaller membership base, UnitedHealthcare's operating profit increased to $2.8 billion from $1.8 billion, and its climbed to 3.3% from 2.1%. Operating reached $25.1 billion through the first nine months of the year, up from $18.6 billion in the same period of 2025. Management expects Medicare Advantage margins near the upper end of its 2% to 4% target range for 2026.